Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Micell Technologies
company
About
Micell Technologies is a biomedical device company developing interventional cardiology systems for vascular drug delivery.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $7M
- Industries
- Biotechnology,Health Care,Medical Device
- Founded date
- Jan 1, 1995
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Micell Technologies, Inc., a biomedical device company, develops interventional cardiology systems for vascular drug delivery. It develops MiStent, a drug-eluting stent that allows control of drug release and pharmacokinetics. The company was founded in 1995 and is based in Raleigh, North Carolina.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$23M
Micell Technologies has raised a total of
$23M
in funding over 2 rounds. Their latest funding was raised on
Oct 1, 2009 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 1, 2009 | Series B | $15M | 1 | — | — | Detail |
| Jul 12, 2007 | Series A | $7M | 1 |
Invemed Catalyst Fund
|
— | Detail |
| Jul 18, 2002 | Series Unknown | $1M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Micell Technologies is funded by 2 investors.
Invemed Catalyst Fund
and Gladwyne Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Invemed Catalyst Fund
|
— | Series B |
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
